PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
Data generation and assessment | ARN | Regulatory risk management | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Docosanoic acid, monoester with glycerol | 250-097-0 | 30233-64-8 | - | - | - | - | 1 | - | - | - | - | Details |
Docosyl acrylate | 242-182-6 | 18299-85-9 | - | - | - | - | 1 | - | - | - | - | Details |
Docosyl methacrylate | 240-714-1 | 16669-27-5 | - | - | - | - | 1 | - | - | - | - | Details |
Docosyl stearate | 244-971-0 | 22413-03-2 | - | - | - | - | 1 | - | - | - | - | Details |
Dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane | 219-196-6 | 2385-85-5 | - | - | - | - | - | - | - | - | - | Details |
Dodecahydro-3,8,8,11a-tetramethyl-5H-3,5a-epoxynaphth[2,1-c]oxepin | 260-686-4 | 57345-19-4 | - | - | - | - | 1 | - | - | - | - | Details |
Dodecahydro-3a,6,6,9a-tetramethylnaphtho[2,1-b]furan | 223-118-6 | 3738-00-9 | - | - | - | - | 1 | - | - | - | - | Details |
Dodecamethylenediamine | 220-489-6 | 2783-17-7 | - | - | - | - | 1 | - | - | - | - | Details |
Dodecanedioic acid, compound with hexane-1,6-diamine (1:1) | 236-143-2 | 13188-60-8 | - | - | - | - | 1 | - | - | - | - | Details |
Dodecanoic acid, ester with 1,2,3-propanetriol | 811-605-1 | 37318-95-9 | - | - | - | - | 1 | - | - | - | - | Details |
Dodecanoic acid, ester with 1,2,3-propanetriol, acetylated | 939-588-7 | - | - | - | - | - | 1 | - | - | - | - | Details |
Dodecenylsuccinic anhydride | 246-917-1 | 25377-73-5 | - | - | - | - | 1 | - | - | - | - | Details |
Dodecyl acetate | 203-995-1 | 112-66-3 | - | - | - | - | - | 1 | - | - | - | Details |
Dodecyl D-glucoside | 248-685-7 | 27836-64-2 | - | - | - | - | 1 | - | - | - | - | Details |
Dodecyl hydrogen sulphate | 205-791-8 | 151-41-7 | - | - | - | - | 1 | - | - | - | - | Details |
Dodecyl isocyanate | 224-111-0 | 4202-38-4 | - | - | - | - | 1 | - | - | - | - | Details |
Dodecyl laurate | 237-725-9 | 13945-76-1 | - | - | - | - | 1 | - | - | - | - | Details |
Dodecyl myristate | 218-039-9 | 2040-64-4 | - | - | - | - | 1 | - | - | - | - | Details |
Dodecyl nonan-1-oate | 241-644-4 | 17671-26-0 | - | - | - | - | 1 | - | - | - | - | Details |
Dodecyl oleate | 252-862-4 | 36078-10-1 | - | - | - | - | 1 | - | - | - | - | Details |
Dodecylbenzene | 204-591-8 | 123-01-3 | - | - | - | - | 1 | - | - | - | - | Details |
Dodecyldimethylamine oxide | 216-700-6 | 1643-20-5 | - | - | - | - | 1 | - | - | - | - | Details |
dodecyldiphenyl phosphate | 431-760-5 | 27460-02-2 | - | - | - | - | 1 | - | - | - | - | Details |
Dodecylphenol | 248-312-8 | 27193-86-8 | - | - | - | - | 1 | - | - | - | - | Details |
Dodecylphosphonic acid | 225-897-8 | 5137-70-2 | - | - | - | - | 1 | - | - | - | - | Details |